Symbols / ZBH Stock $88.57 +1.64% Zimmer Biomet Holdings, Inc.

Healthcare • Medical Devices • United States • NYQ
ZBH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Ivan Tornos
Exch · Country NYQ · United States
Market Cap 17.13B
Enterprise Value 24.25B
Income 761.20M
Sales 8.41B
FCF (ttm) 1.04B
Book/sh 65.53
Cash/sh 2.47
Employees 17,000
Insider 10d —
IPO Jul 25, 2001
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 24.87%
P/E 22.95
Forward P/E 9.85
PEG 0.63
P/S 2.04
P/B 1.35
P/C —
EV/EBITDA 9.40
EV/Sales 2.88
Quick Ratio 0.77
Current Ratio 1.73
Debt/Eq 59.83
LT Debt/Eq —
EPS (ttm) 3.86
EPS next Y 8.99
EPS Growth 34.10%
Revenue Growth 9.30%
EPS Gr Q/Q 30.80%
Rev Gr Q/Q —
Earnings (next) 2026-04-28
Earnings (prior) 2026-04-28
ROA 4.10%
ROE 6.07%
ROIC —
Gross Margin 70.18%
Oper. Margin 19.69%
Profit Margin 9.05%
Shs Outstand 193.46M
Shs Float 192.93M
Insider Own 0.16%
Instit Own 106.60%
Short Float 5.92%
Short Ratio 3.54
Short Interest 8.72M
52W High 108.29
vs 52W High -18.21%
52W Low 79.12
vs 52W Low 11.94%
Beta 0.47
Impl. Vol. 1.56%
Rel Volume 0.57
Avg Volume 2.28M
Volume 1.30M
Target (mean) $98.70
Tgt Median $94.00
Tgt Low $83.00
Tgt High $130.00
# Analysts 20
Recom Hold
Prev Close $87.14
Price $88.57
Change 1.64%
About

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$98.70
Mean price target
2. Current target
$88.57
Latest analyst target
3. DCF / Fair value
$97.15
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$88.57
Low
$83.00
High
$130.00
Mean
$98.70

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-28 main Citigroup Neutral → Neutral $93
2026-04-29 main JP Morgan Neutral → Neutral $95
2026-04-29 main Citigroup Neutral → Neutral $95
2026-04-29 main Citizens Market Outperform → Market Outperform $105
2026-04-29 main Wells Fargo Equal-Weight → Equal-Weight $90
2026-04-29 main Barclays Underweight → Underweight $94
2026-04-29 reit Truist Securities Hold → Hold $92
2026-04-29 main Stifel Buy → Buy $105
2026-04-13 init Leerink Partners — → Market Perform $101
2026-03-23 down BTIG Buy → Neutral —
2026-02-12 main Barclays Underweight → Underweight $100
2026-02-11 main Citigroup Neutral → Neutral $98
2026-02-11 main Wells Fargo Equal-Weight → Equal-Weight $98
2026-02-10 reit BTIG Buy → Buy $112
2026-02-10 reit Needham Hold → Hold —
2026-01-28 main UBS Sell → Sell $86
2026-01-09 main Bernstein Market Perform → Market Perform $99
2026-01-08 reit BTIG Buy → Buy $112
2026-01-05 up Evercore ISI Group In-Line → Outperform $120
2025-12-16 down Baird Outperform → Neutral $100
News
RSS: Latest ZBH news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-29 YI SANG Officer — 5,000 $82.64 $413,216
2026-04-01 NOOR JEHANZEB Officer — 6,626 — —
2026-03-12 WINKLER LORI Officer — 2,650 $94.66 $250,849
2026-03-06 WINKLER LORI Officer — 5,634 — —
2026-03-06 VAN ZUILEN WILFRED Officer — 7,004 — —
2026-03-06 TORNOS IVAN Chief Executive Officer — 34,704 — —
2026-03-06 YI SANG Officer — 9,414 — —
2026-03-06 STELLATO PAUL A Officer — 1,970 — —
2026-03-06 UPADHYAY SUKETU P Chief Financial Officer — 14,776 — —
2026-03-06 PHIPPS CHAD F Officer — 6,786 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
8,231.50
+7.20%
7,678.60
+3.85%
7,394.20
+6.55%
6,939.90
Operating Revenue
8,231.50
+7.20%
7,678.60
+3.85%
7,394.20
+6.55%
6,939.90
Cost Of Revenue
2,493.70
+13.81%
2,191.20
+5.15%
2,083.80
+3.18%
2,019.50
Reconciled Cost Of Revenue
2,065.80
+15.61%
1,786.80
+5.50%
1,693.60
+4.55%
1,619.90
Gross Profit
5,737.80
+4.56%
5,487.40
+3.33%
5,310.40
+7.93%
4,920.40
Operating Expense
4,381.60
+10.67%
3,959.10
+2.59%
3,859.10
+3.51%
3,728.30
Research And Development
458.50
+4.82%
437.40
-4.64%
458.70
+12.98%
406.00
Selling General And Administration
3,257.20
+11.17%
2,929.80
+3.20%
2,838.90
+2.80%
2,761.70
Other Operating Expenses
—
—
—
33.80
Total Expenses
6,875.30
+11.79%
6,150.30
+3.49%
5,942.90
+3.39%
5,747.80
Operating Income
1,356.20
-11.26%
1,528.30
+5.31%
1,451.30
+21.74%
1,192.10
Total Operating Income As Reported
1,098.10
-14.59%
1,285.70
+0.63%
1,277.70
+83.50%
696.30
EBITDA
2,217.40
-1.49%
2,250.90
+1.38%
2,220.20
+48.54%
1,494.70
Normalized EBITDA
2,475.50
-0.72%
2,493.50
+4.16%
2,393.80
+20.26%
1,990.50
Reconciled Depreciation
1,093.80
+9.79%
996.30
+4.69%
951.70
+2.73%
926.40
EBIT
1,123.60
-10.44%
1,254.60
-1.10%
1,268.50
+123.21%
568.30
Total Unusual Items
-258.10
-6.39%
-242.60
-39.75%
-173.60
+64.99%
-495.80
Total Unusual Items Excluding Goodwill
-258.10
-6.39%
-242.60
-39.75%
-173.60
+64.99%
-495.80
Special Income Charges
-258.10
-6.39%
-242.60
-39.75%
-173.60
+64.99%
-495.80
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
—
0.00
0.00
-100.00%
292.80
Restructuring And Mergern Acquisition
258.10
+6.39%
242.60
+39.75%
173.60
-14.48%
203.00
Net Income
705.10
-21.98%
903.80
-11.74%
1,024.00
+342.52%
231.40
Pretax Income
830.80
-19.85%
1,036.60
-2.88%
1,067.30
+164.51%
403.50
Net Non Operating Interest Income Expense
-292.80
-34.31%
-218.00
-8.35%
-201.20
-22.09%
-164.80
Interest Expense Non Operating
292.80
+34.31%
218.00
+8.35%
201.20
+22.09%
164.80
Net Interest Income
-292.80
-34.31%
-218.00
-8.35%
-201.20
-22.09%
-164.80
Interest Expense
292.80
+34.31%
218.00
+8.35%
201.20
+22.09%
164.80
Other Income Expense
-232.60
+15.02%
-273.70
-49.64%
-182.90
+70.68%
-623.80
Other Non Operating Income Expenses
25.50
+181.99%
-31.10
-234.41%
-9.30
+92.73%
-128.00
Tax Provision
125.70
-4.34%
131.40
+211.37%
42.20
-62.42%
112.30
Tax Rate For Calcs
0.00
+19.36%
0.00
+216.90%
0.00
-85.66%
0.00
Tax Effect Of Unusual Items
-39.05
-26.98%
-30.75
-342.86%
-6.94
+94.98%
-138.33
Net Income Including Noncontrolling Interests
705.10
-22.11%
905.20
-11.70%
1,025.10
+341.09%
232.40
Net Income From Continuing Operation Net Minority Interest
705.10
-21.98%
903.80
-11.74%
1,024.00
+252.86%
290.20
Net Income From Continuing And Discontinued Operation
705.10
-21.98%
903.80
-11.74%
1,024.00
+342.52%
231.40
Net Income Continuous Operations
705.10
-22.11%
905.20
-11.70%
1,025.10
+252.03%
291.20
Net Income Discontinuous Operations
—
0.00
0.00
+100.00%
-58.80
Minority Interests
0.10
+106.67%
-1.50
-36.36%
-1.10
-10.00%
-1.00
Normalized Income
924.15
-17.16%
1,115.65
-6.30%
1,190.66
+83.84%
647.67
Net Income Common Stockholders
705.10
-21.98%
903.80
-11.74%
1,024.00
+342.52%
231.40
Diluted EPS
3.55
-19.86%
4.43
-9.22%
4.88
+343.64%
1.10
Basic EPS
3.56
-20.00%
4.45
-9.37%
4.91
+346.36%
1.10
Basic Average Shares
198.00
-2.51%
203.10
-2.68%
208.70
-0.43%
209.60
Diluted Average Shares
198.70
-2.55%
203.90
-2.77%
209.70
-0.29%
210.30
Diluted NI Availto Com Stockholders
705.10
-21.98%
903.80
-11.74%
1,024.00
+342.52%
231.40
Amortization
665.90
+12.50%
591.90
+5.41%
561.50
+6.59%
526.80
Amortization Of Intangibles Income Statement
665.90
+12.50%
591.90
+5.41%
561.50
+6.59%
526.80
Depreciation Amortization Depletion Income Statement
665.90
+12.50%
591.90
+5.41%
561.50
+6.59%
526.80
Depreciation And Amortization In Income Statement
665.90
+12.50%
591.90
+5.41%
561.50
+6.59%
526.80
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
23,091.70
+8.08%
21,365.30
-0.61%
21,496.90
+2.05%
21,066.00
Current Assets
5,119.90
+9.60%
4,671.50
+1.35%
4,609.50
+4.12%
4,427.30
Cash Cash Equivalents And Short Term Investments
591.90
+12.64%
525.50
+26.38%
415.80
+10.67%
375.70
Cash And Cash Equivalents
591.90
+12.64%
525.50
+26.38%
415.80
+10.67%
375.70
Receivables
1,704.40
+15.11%
1,480.70
+2.66%
1,442.40
+4.41%
1,381.50
Accounts Receivable
1,704.40
+15.11%
1,480.70
+2.66%
1,442.40
+4.41%
1,381.50
Gross Accounts Receivable
1,814.20
+15.27%
1,573.90
+3.72%
1,517.50
+3.95%
1,459.90
Allowance For Doubtful Accounts Receivable
-109.80
-17.81%
-93.20
-24.10%
-75.10
+4.21%
-78.40
Inventory
2,286.40
+2.29%
2,235.30
-6.28%
2,385.20
+11.08%
2,147.20
Raw Materials
273.20
-5.30%
288.50
-6.18%
307.50
+17.68%
261.30
Work In Process
181.00
+3.37%
175.10
-28.97%
246.50
+6.76%
230.90
Finished Goods
1,832.20
+3.41%
1,771.70
-3.25%
1,831.20
+10.65%
1,655.00
Prepaid Assets
—
—
—
198.40
Assets Held For Sale Current
—
—
—
0.00
Other Current Assets
537.20
+24.93%
430.00
+17.45%
366.10
-29.99%
522.90
Total Non Current Assets
17,971.80
+7.66%
16,693.80
-1.15%
16,887.40
+1.49%
16,638.70
Net PPE
2,207.10
+7.73%
2,048.80
-0.56%
2,060.40
+10.03%
1,872.50
Gross PPE
7,257.40
+8.48%
6,690.20
-1.12%
6,766.20
+4.77%
6,458.40
Accumulated Depreciation
-5,050.30
-8.81%
-4,641.40
+1.37%
-4,705.80
-2.61%
-4,585.90
Properties
0.00
0.00
0.00
0.00
Land And Improvements
22.50
+21.62%
18.50
-2.12%
18.90
-1.56%
19.20
Buildings And Improvements
2,419.80
+6.45%
2,273.10
+1.21%
2,245.90
+7.28%
2,093.40
Machinery Furniture Equipment
623.80
+8.47%
575.10
+4.15%
552.20
+6.56%
518.20
Construction In Progress
286.30
+22.40%
233.90
+16.60%
200.60
+39.21%
144.10
Other Properties
3,905.00
+8.79%
3,589.60
-4.24%
3,748.60
+1.77%
3,683.50
Goodwill And Other Intangible Assets
14,664.40
+8.23%
13,549.50
-0.92%
13,674.90
+0.23%
13,644.00
Goodwill
9,947.10
+11.13%
8,951.10
+1.50%
8,818.50
+2.78%
8,580.20
Other Intangible Assets
4,717.30
+2.59%
4,598.40
-5.31%
4,856.40
-4.10%
5,063.80
Other Non Current Assets
1,100.30
+0.44%
1,095.50
-4.91%
1,152.10
+2.66%
1,122.20
Total Liabilities Net Minority Interest
10,385.90
+16.84%
8,889.10
-1.33%
9,008.80
-0.33%
9,039.00
Current Liabilities
2,583.70
+5.42%
2,450.90
-14.23%
2,857.40
+21.17%
2,358.20
Payables And Accrued Expenses
1,614.60
+26.70%
1,274.30
-21.88%
1,631.30
+24.42%
1,311.10
Payables
303.00
+55.70%
194.60
-52.61%
410.60
+4.58%
392.60
Accounts Payable
303.00
+55.70%
194.60
-52.61%
410.60
+15.96%
354.10
Current Accrued Expenses
1,311.60
+21.48%
1,079.70
-11.55%
1,220.70
+32.90%
918.50
Pensionand Other Post Retirement Benefit Plans Current
—
—
417.10
+24.06%
336.20
Total Tax Payable
—
—
61.20
+58.96%
38.50
Income Tax Payable
—
—
61.20
+58.96%
38.50
Current Debt And Capital Lease Obligation
587.10
-31.97%
863.00
-4.11%
900.00
+65.35%
544.30
Current Debt
587.10
-31.97%
863.00
-4.11%
900.00
+65.35%
544.30
Other Current Borrowings
587.10
-31.97%
863.00
-4.11%
900.00
+65.35%
544.30
Current Deferred Liabilities
—
—
—
—
Current Deferred Revenue
—
—
—
—
Other Current Liabilities
382.00
+21.81%
313.60
-3.83%
326.10
-35.14%
502.80
Total Non Current Liabilities Net Minority Interest
7,802.20
+21.19%
6,438.20
+4.66%
6,151.40
-7.92%
6,680.80
Liabilities Heldfor Sale Non Current
—
—
—
0.00
Long Term Debt And Capital Lease Obligation
6,932.00
+29.77%
5,341.60
+9.73%
4,867.90
-5.52%
5,152.20
Long Term Debt
6,932.00
+29.77%
5,341.60
+9.73%
4,867.90
-5.52%
5,152.20
Tradeand Other Payables Non Current
—
—
273.70
-35.02%
421.20
Non Current Deferred Liabilities
244.10
-30.75%
352.50
-1.43%
357.60
-24.68%
474.80
Non Current Deferred Taxes Liabilities
244.10
-30.75%
352.50
-1.43%
357.60
-24.68%
474.80
Other Non Current Liabilities
626.10
-15.86%
744.10
-19.63%
925.90
+46.36%
632.60
Stockholders Equity
12,697.70
+1.84%
12,468.10
-0.10%
12,480.50
+3.83%
12,020.30
Common Stock Equity
12,697.70
+1.84%
12,468.10
-0.10%
12,480.50
+3.83%
12,020.30
Capital Stock
3.20
+0.00%
3.20
+0.00%
3.20
+3.23%
3.10
Common Stock
3.20
+0.00%
3.20
+0.00%
3.20
+3.23%
3.10
Share Issued
318.68
+0.38%
317.47
+0.40%
316.20
+0.76%
313.80
Ordinary Shares Number
195.48
-1.80%
199.07
-3.17%
205.60
-1.63%
209.00
Treasury Shares Number
123.20
+4.05%
118.40
+7.05%
110.60
+5.53%
104.80
Additional Paid In Capital
10,178.60
+1.40%
10,038.10
+1.95%
9,846.10
+3.60%
9,504.40
Retained Earnings
11,611.00
+4.65%
11,095.30
+6.84%
10,384.50
+8.63%
9,559.30
Gains Losses Not Affecting Retained Earnings
-205.70
+21.73%
-262.80
-37.59%
-191.00
-6.53%
-179.30
Treasury Stock
8,889.40
+5.75%
8,405.70
+11.15%
7,562.30
+10.12%
6,867.20
Minority Interest
8.10
+0.00%
8.10
+5.19%
7.70
+14.93%
6.70
Other Equity Adjustments
-205.70
+21.73%
-262.80
-37.59%
-191.00
-6.53%
-179.30
Total Equity Gross Minority Interest
12,705.80
+1.84%
12,476.20
-0.10%
12,488.10
+3.83%
12,027.00
Total Capitalization
19,629.70
+10.22%
17,809.70
+2.66%
17,348.40
+1.02%
17,172.50
Working Capital
2,536.20
+14.21%
2,220.60
+26.74%
1,752.10
-15.32%
2,069.10
Invested Capital
20,216.80
+8.27%
18,672.70
+2.33%
18,248.40
+3.00%
17,716.80
Total Debt
7,519.10
+21.19%
6,204.60
+7.57%
5,767.90
+1.25%
5,696.50
Net Debt
6,927.20
+21.98%
5,679.10
+6.11%
5,352.10
+0.59%
5,320.80
Net Tangible Assets
-1,966.70
-81.87%
-1,081.40
+9.46%
-1,194.40
+26.44%
-1,623.70
Tangible Book Value
-1,966.70
-81.87%
-1,081.40
+9.46%
-1,194.40
+26.44%
-1,623.70
Derivative Product Liabilities
—
—
-144.70
+15.87%
-172.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,697.10
+13.19%
1,499.40
-5.20%
1,581.60
+23.11%
1,284.70
Cash Flow From Continuing Operating Activities
1,697.10
+13.19%
1,499.40
-5.20%
1,581.60
+16.62%
1,356.20
Cash From Discontinued Operating Activities
—
0.00
0.00
+100.00%
-71.50
Net Income From Continuing Operations
705.10
-22.11%
905.20
-11.70%
1,025.10
+252.03%
291.20
Depreciation Amortization Depletion
1,093.80
+9.79%
996.30
+4.69%
951.70
+2.73%
926.40
Depreciation And Amortization
1,093.80
+9.79%
996.30
+4.69%
951.70
+2.73%
926.40
Other Non Cash Items
0.10
—
—
—
Stock Based Compensation
90.20
-10.69%
101.00
+1.20%
99.80
-4.95%
105.00
Asset Impairment Charge
—
0.00
0.00
-100.00%
292.80
Deferred Tax
-87.20
-82.81%
-47.70
+50.47%
-96.30
-49.53%
-64.40
Deferred Income Tax
-87.20
-82.81%
-47.70
+50.47%
-96.30
-49.53%
-64.40
Operating Gains Losses
—
—
-2.50
-102.14%
116.60
Gain Loss On Investment Securities
—
—
—
116.60
Change In Working Capital
-104.90
+76.97%
-455.40
-14.22%
-398.70
-28.03%
-311.40
Change In Receivables
-127.30
-41.92%
-89.70
-72.83%
-51.90
+71.90%
-184.70
Change In Inventory
98.20
+96.79%
49.90
+120.76%
-240.40
-217.99%
-75.60
Change In Payables And Accrued Expense
101.80
+131.61%
-322.00
-482.28%
-55.30
-153.69%
103.00
Change In Other Working Capital
-177.60
-89.74%
-93.60
-83.17%
-51.10
+66.84%
-154.10
Investing Cash Flow
-1,975.70
-122.46%
-888.10
-14.02%
-778.90
-47.18%
-529.20
Cash Flow From Continuing Investing Activities
-1,975.70
-122.46%
-888.10
-14.02%
-778.90
-49.21%
-522.00
Cash From Discontinued Investing Activities
—
0.00
0.00
+100.00%
-7.20
Net PPE Purchase And Sale
-224.50
-10.16%
-203.80
+29.99%
-291.10
-54.92%
-187.90
Purchase Of PPE
-224.50
-10.16%
-203.80
+29.99%
-291.10
-54.92%
-187.90
Capital Expenditure
-276.90
+22.39%
-356.80
+9.56%
-394.50
-81.30%
-217.60
Net Investment Purchase And Sale
-300.90
-37.90%
-218.20
+21.60%
-278.30
-64.77%
-168.90
Purchase Of Investment
-300.90
-25.22%
-240.30
+22.91%
-311.70
-20.67%
-258.30
Sale Of Investment
—
22.10
-33.83%
33.40
-62.64%
89.40
Net Business Purchase And Sale
-1,393.20
-404.23%
-276.30
-104.82%
-134.90
-35.17%
-99.80
Purchase Of Business
-1,393.20
-404.23%
-276.30
-104.82%
-134.90
-35.17%
-99.80
Gain Loss On Sale Of Business
—
0.00
+100.00%
-2.50
-102.14%
116.60
Net Intangibles Purchase And Sale
-52.40
+65.75%
-153.00
-47.97%
-103.40
-248.15%
-29.70
Purchase Of Intangibles
-52.40
+65.75%
-153.00
-47.97%
-103.40
-248.15%
-29.70
Net Other Investing Changes
-4.70
+87.23%
-36.80
-227.78%
28.80
+180.67%
-35.70
Financing Cash Flow
326.00
+167.29%
-484.50
+36.54%
-763.50
+9.52%
-843.80
Cash Flow From Continuing Financing Activities
326.00
+167.29%
-484.50
+36.54%
-763.50
+1.57%
-775.70
Net Issuance Payments Of Debt
1,029.10
+91.89%
536.30
+882.23%
54.60
+105.15%
-1,060.70
Issuance Of Debt
2,492.10
+73.51%
1,436.30
+187.37%
499.80
+502.17%
83.00
Repayment Of Debt
-1,463.00
-62.56%
-900.00
-102.16%
-445.20
+70.69%
-1,518.70
Long Term Debt Issuance
2,492.10
+73.51%
1,436.30
+187.37%
499.80
+502.17%
83.00
Long Term Debt Payments
-1,463.00
-62.56%
-900.00
-102.16%
-445.20
+70.69%
-1,518.70
Net Long Term Debt Issuance
1,029.10
+91.89%
536.30
+882.23%
54.60
+103.80%
-1,435.70
Net Short Term Debt Issuance
—
-50.00
+84.62%
-325.00
-186.67%
375.00
Net Common Stock Issuance
-487.00
+43.89%
-868.00
-25.40%
-692.20
-447.63%
-126.40
Common Stock Payments
-487.00
+43.89%
-868.00
-25.40%
-692.20
-447.63%
-126.40
Common Stock Dividend Paid
-190.30
+2.91%
-196.00
+2.44%
-200.90
+0.15%
-201.20
Cash Dividends Paid
-190.30
+2.91%
-196.00
+2.44%
-200.90
+0.15%
-201.20
Repurchase Of Capital Stock
-487.00
+43.89%
-868.00
-25.40%
-692.20
-447.63%
-126.40
Proceeds From Stock Option Exercised
39.70
-51.64%
82.10
-18.79%
101.10
+29.45%
78.10
Net Other Financing Charges
-65.50
-68.38%
-38.90
-49.04%
-26.10
-104.88%
534.50
Changes In Cash
47.40
-62.62%
126.80
+223.47%
39.20
+144.39%
-88.30
Effect Of Exchange Rate Changes
19.00
+211.11%
-17.10
-2000.00%
0.90
+106.21%
-14.50
Beginning Cash Position
525.50
+26.38%
415.80
+10.67%
375.70
-21.48%
478.50
End Cash Position
591.90
+12.64%
525.50
+26.38%
415.80
+10.67%
375.70
Free Cash Flow
1,420.20
+24.30%
1,142.60
-3.75%
1,187.10
+11.25%
1,067.10
Cash From Discontinued Financing Activities
—
0.00
0.00
+100.00%
-68.10
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category